Evidence map›Paper›PMID 35116517›Full record

ArticleTranslational cancer research2021

A fatal multiple-lesion, inflammatory, pseudotumor in the lung: a rare case report.

Na Li, Changpeng Zou, Siming Gao, Ying Guo, Wei Wang, Yan Guo, Juan Zhang, Cong Wang, Yonghui An

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Translational cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Na LiDepartment of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Changpeng ZouDepartment of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Siming GaoDepartment of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Ying GuoDepartment of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Wei WangDepartment of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Yan GuoDepartment of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Juan ZhangDepartment of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Cong WangDepartment of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Yonghui AnDepartment of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Hebei Medical University · CNFirst Affiliated Hospital of Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An inflammatory pseudotumor is considered a benign form of lesion marked by a proliferation of myofibroblasts with different degrees of inflammatory infiltrates. Pulmonary inflammatory pseudotumors (PIPs) are extremely rare in middle-aged adults. Normally, a PIP has a single lesion, and can be controlled constantly by surgery and drugs. In this paper, we report a case study of a 51-year-old male patient who presented with multiple inflammatory pseudotumors in lungs, thoracic spine, ribs, left humerusl, derived from PIPs throughout his body, which indicated a long disease term and significant recrudescence. After 6 surgeries (a wedge resection of the right lower lobe, a removal of three thoracic vertebral lesions, a removal of left humeral tumor lesion, a right lower lobe resection, local cryoablation of right lung, debridement of left upper-arm osteomyelitis and soft tissue infection), radiotherapy for lesions of left humerus destruction at a total dose of 20 Gy/10 F, and systematic treatments (30 mg prednisone acetate daily for 6 weeks, 50 mg compound cyclophosphamide tablets for 2 weeks; antibiotics, blood transfusions, nutritional support), his symptoms improved but reoccurred. The patient ultimately died of septic shock. Our case report highlights that the progression of a PIP to a malignant form requires further research. A multiple-lesion PIP that does not respond to systemic treatment can be highly dangerous.

Indexed as

case reportinflammatory myofibroblastic tumorInflammatory pseudotumorlung tumorpulmonary pseudotumor

Identifiers

PMID35116517
PMCPMC8797402
OpenAlexW3157300600

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.